June 17, 2025

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Unveiling a 36% Upside Potential for Investors

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a key player in the healthcare sector with a focus on medical devices, is capturing investor attention with its impressive..

Agios Pharmaceuticals (AGIO) Stock Analysis: Exploring a 44.66% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent player in the biotechnology sector, is gaining attention from investors due to its promising developments in cellular metabolism medicines...

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 63% Upside Potential in the Healthcare Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands out in the healthcare sector, particularly within the medical devices industry, with its robust portfolio of diabetes management solutions...

agilon health, inc. (AGL) Stock Analysis: Exploring the 95% Potential Upside

For investors eyeing opportunities in the healthcare sector, agilon health, inc. (NYSE: AGL) presents a compelling case, especially with a potential upside of 95.12% as indicated..

Evolent Health, Inc (EVH) Stock Analysis: A Deep Dive into Its 84% Potential Upside

Evolent Health, Inc. (NASDAQ: EVH) is an intriguing player in the healthcare sector, specifically within the health information services industry. Headquartered in Arlington, Virginia, the company..

Opko Health, Inc. (OPK) Stock Analysis: A Look at the 200% Potential Upside

Opko Health, Inc. (NASDAQ: OPK), a diversified healthcare company, stands out in the healthcare sector with its dual focus on diagnostics and pharmaceuticals. Headquartered in Miami,..

Addus HomeCare Corporation (ADUS): Investor Outlook Reveals 19% Upside Potential

Investors eyeing the healthcare sector may find Addus HomeCare Corporation (NASDAQ: ADUS) an intriguing option, as the company offers a compelling blend of robust growth prospects..

Harrow, Inc. (HROW): Analyst Ratings Signal Strong Buy with 80% Upside Potential

Harrow, Inc. (NASDAQ: HROW), a key player in the ophthalmic pharmaceutical sector, has been gaining traction among investors due to its robust growth potential and promising..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A Compelling 40% Upside Potential for Innovators in Cell Therapy

For investors seeking exposure to the dynamic healthcare sector, BioLife Solutions, Inc. (NASDAQ: BLFS) presents a fascinating opportunity. With a market capitalization of $1.06 billion, this..

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook on a 22.68% Potential Upside

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), headquartered in Atlanta, Georgia, stands as a prominent player in the healthcare sector, focusing on providing diversified home care services..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating a 20% Potential Upside for Investors

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a key player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for..

Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook on a Biotech with a 22.85% Upside Potential

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) is drawing significant attention from investors, particularly those with an interest in the healthcare sector. This Canadian biotechnology company, with a..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a 99% Potential Upside Amidst Analyst Optimism

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a key player in the biotechnology sector, is capturing investor attention with its promise of significant upside potential. Despite some challenging..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 165% Potential Upside in the Biotech Space

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is making waves in the biotechnology sector with a market capitalization of $1.54 billion. Based in Boulder, Colorado, this innovative biopharmaceutical..

MannKind Corporation (MNKD) Stock Analysis: Evaluating a Potential 154.97% Upside

MannKind Corporation (NASDAQ: MNKD) stands out in the healthcare sector as a biotechnology company with a targeted focus on endocrine and orphan lung diseases. With a..

GoodRx Holdings, Inc. (GDRX) Investor Outlook: Exploring a 42.59% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) offers investors a unique opportunity within the healthcare sector, specifically in the health information services industry. With a market capitalization of..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a 130% Potential Upside

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a promising player in the biotechnology sector, is capturing investor attention with its remarkable potential upside of 130.76%. This precision medicine..

Integra LifeSciences Holdings (IART) Stock Analysis: Exploring a 30% Potential Upside Amidst Healthcare Innovation

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a pivotal player in the healthcare sector, specializes in medical devices catering to neurosurgery, neurocritical care, and wound treatment. With..

Zai Lab Limited (ZLAB): An Investor’s Insight into Potential 36% Upside in Biotech Innovation

In the dynamic world of biotechnology, Zai Lab Limited (NASDAQ: ZLAB) emerges as a compelling player with a promising portfolio and significant market presence. Based in..

The Pennant Group, Inc. (PNTG) Stock Analysis: Unlocking a 17.98% Upside in the Healthcare Sector

Investors looking to capitalize on the robust growth within the healthcare sector should consider The Pennant Group, Inc. (NASDAQ: PNTG). This burgeoning company, with a market..

Search

Funds

June 17, 2025

Search

Funds

June 17, 2025

FTSE 100

Funds